NEW YORK, Nov. 23 (GenomeWeb News) - Shares in DeCode Genetics were up 5.20 percent at $6.47 in mid-afternoon trading after the company announced plans to jointly develop and market cardiovascular and cerebrovascular drugs with Roche.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.